• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

母乳喂养能保护母亲免于肥胖吗?

Does Breast Feeding Protect Mothers From Obesity?

作者信息

Coşgun Süleyman, Ünal Derya, Çalışkan Kartal Aysun, Bedir Osman

机构信息

Internal Medicine, Gastroenterology, Kütahya University of Health Sciences, Kütahya, TUR.

Internal Medicine, Kütahya University of Health Sciences, Kütahya, TUR.

出版信息

Cureus. 2024 Sep 25;16(9):e70217. doi: 10.7759/cureus.70217. eCollection 2024 Sep.

DOI:10.7759/cureus.70217
PMID:39463500
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11512000/
Abstract

BACKGROUND

Hepatosteatosis, which we frequently observe today with change in lifestyle, is often unnoticed, but preventable and reversible; if not prevented, it can lead to serious comorbidities. There is contradicting evidence in the literature; we believe that breastfeeding has a protective effect on hepatosteatosis. In this cross-sectional study we conducted, we aimed to examine the relationship between breastfeeding duration, metabolic parameters and fatty liver.

METHODS

We examined the data of 135 patients aged 20-40 years who have had at least one pregnancy and were admitted to our polyclinic. Forty-five healthcare staff who never breastfed were included in the control group. Measurements of height and weight were taken, and number of children and total breastfeeding time were questioned. Blood values were measured to calculate insulin resistance, non-alcoholic fatty liver disease (NAFLD) fibrosis score and Fibrosis-4 (FIB-4) score.

RESULTS

Consequently, there was no significant correlation between total breastfeeding time and body mass index (BMI), NAFLD fibrosis score, Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) value and hemoglobin A1C (HbA1C). When two groups were formed as patients breastfeeding for less than six months and patients breastfeeding for more than six months, a significant difference in BMI was observed between these two groups (p: 0.02). There was a significant relationship between BMI and NAFLD (p: 0.00) and HOMA-IR (p: 0.00). It was observed that there was a significant difference between BMI FIB-4 and NAFLD fibrosis scores of the control group and breastfed group.

CONCLUSIONS

Lactation should be maintained for at least six months for maternal health together with the baby's health, and more comprehensive studies should be conducted for long-term data.

摘要

背景

肝脂肪变性在当今因生活方式改变而频繁出现,常常未被察觉,但可预防且可逆;若不加以预防,可能导致严重的合并症。文献中有相互矛盾的证据;我们认为母乳喂养对肝脂肪变性有保护作用。在我们进行的这项横断面研究中,我们旨在研究母乳喂养持续时间、代谢参数与脂肪肝之间的关系。

方法

我们检查了135名年龄在20至40岁之间、至少有过一次怀孕经历且前来我们门诊就诊的患者的数据。45名从未进行过母乳喂养的医护人员被纳入对照组。测量了身高和体重,并询问了子女数量和总母乳喂养时间。测量血液值以计算胰岛素抵抗、非酒精性脂肪性肝病(NAFLD)纤维化评分和纤维化-4(FIB-4)评分。

结果

结果显示,总母乳喂养时间与体重指数(BMI)、NAFLD纤维化评分、胰岛素抵抗稳态模型评估(HOMA-IR)值和糖化血红蛋白(HbA1C)之间无显著相关性。当将两组分为母乳喂养少于六个月的患者和母乳喂养超过六个月的患者时,观察到这两组之间的BMI存在显著差异(p:0.02)。BMI与NAFLD(p:0.00)和HOMA-IR(p:0.00)之间存在显著关系。观察到对照组和母乳喂养组的BMI、FIB-4和NAFLD纤维化评分之间存在显著差异。

结论

为了母亲和婴儿的健康,母乳喂养应至少持续六个月,并且应该进行更全面的研究以获取长期数据。

相似文献

1
Does Breast Feeding Protect Mothers From Obesity?母乳喂养能保护母亲免于肥胖吗?
Cureus. 2024 Sep 25;16(9):e70217. doi: 10.7759/cureus.70217. eCollection 2024 Sep.
2
Infant nutrition and maternal obesity influence the risk of non-alcoholic fatty liver disease in adolescents.婴儿营养和产妇肥胖会影响青少年非酒精性脂肪肝的发病风险。
J Hepatol. 2017 Sep;67(3):568-576. doi: 10.1016/j.jhep.2017.03.029. Epub 2017 Jun 12.
3
Evaluation of clinical, endocrine and metabolic findings in obese children with and without hepatosteatosis.评估伴有和不伴有肝脂肪变性的肥胖儿童的临床、内分泌和代谢发现。
J Pediatr Endocrinol Metab. 2021 Jun 18;34(9):1081-1087. doi: 10.1515/jpem-2021-0034. Print 2021 Sep 27.
4
The association of the steatosis severity, NAFLD fibrosis score and FIB-4 index with atherogenic dyslipidaemia in adult patients with NAFLD: A cross-sectional study.非酒精性脂肪性肝病患者非酒精性脂肪性肝病纤维化评分、脂肪变性严重程度与 FIB-4 指数与动脉粥样硬化性血脂异常的关系:一项横断面研究。
Int J Clin Pract. 2021 Jun;75(6):e14131. doi: 10.1111/ijcp.14131. Epub 2021 Mar 21.
5
Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease.FLIP算法和SAF评分在非酒精性脂肪性肝病患者中的临床验证。
J Hepatol. 2020 May;72(5):828-838. doi: 10.1016/j.jhep.2019.12.008. Epub 2019 Dec 17.
6
The Relationship between Insulin Resistance and Liver Damage in non-alcoholic Fatty Liver Patients.非酒精性脂肪肝患者胰岛素抵抗与肝损伤的关系
Sisli Etfal Hastan Tip Bul. 2020 Dec 11;54(4):411-415. doi: 10.14744/SEMB.2018.83604. eCollection 2020.
7
Noninvasive fibrosis tools in NAFLD: validation of APRI, BARD, FIB-4, NAFLD fibrosis score, and Hepamet fibrosis score in a Portuguese population.非酒精性脂肪性肝病无创性纤维化工具:APRI、BARD、FIB-4、NAFLD 纤维化评分和 Hepamet 纤维化评分在葡萄牙人群中的验证。
Postgrad Med. 2022 May;134(4):435-440. doi: 10.1080/00325481.2022.2058285. Epub 2022 Mar 30.
8
Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD.脂肪组织胰岛素抵抗可预测2型糖尿病合并非酒精性脂肪性肝病患者肝纤维化的严重程度。
J Clin Endocrinol Metab. 2023 Apr 13;108(5):1192-1201. doi: 10.1210/clinem/dgac660.
9
IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.2 型糖尿病对非酒精性脂肪性肝病患者非酒精性脂肪性肝炎和肝纤维化进展的影响。
Endocr Pract. 2020 Apr;26(4):444-453. doi: 10.4158/EP-2019-0342. Epub 2020 Jan 22.
10
FICK-3 Score Combining Fibrosis-4, Insulin Resistance and Cytokeratin-18 in Predicting Non-alcoholic Steatohepatitis in NAFLD Egyptian Patients.FICK-3评分结合纤维化-4、胰岛素抵抗和细胞角蛋白-18预测埃及非酒精性脂肪性肝病患者的非酒精性脂肪性肝炎
Pak J Biol Sci. 2019 Jan;22(10):457-466. doi: 10.3923/pjbs.2019.457.466.

引用本文的文献

1
Self-Reported Weight Gain After the Age of 20 and Risk of Steatotic Liver Disease.20岁后自我报告的体重增加与脂肪性肝病风险
Nutrients. 2025 Aug 6;17(15):2566. doi: 10.3390/nu17152566.

本文引用的文献

1
The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD).2 型糖尿病(T2DM)、胰岛素抵抗(IR)与非酒精性脂肪性肝病(NAFLD)之间错综复杂的关系。
J Diabetes Res. 2020 Jul 31;2020:3920196. doi: 10.1155/2020/3920196. eCollection 2020.
2
Maternal pre-pregnancy body mass index, gestational weight gain and breastfeeding outcomes: a cross-sectional analysis.孕前母体体重指数、孕期体重增加与母乳喂养结局:一项横断面分析
BMC Pregnancy Childbirth. 2020 Aug 17;20(1):471. doi: 10.1186/s12884-020-03156-8.
3
Dose-Response Relationships between Breastfeeding and Postpartum Weight Retention Differ by Pre-Pregnancy Body-Mass Index in Taiwanese Women.台湾女性母乳喂养与产后体重滞留的剂量-反应关系因孕前体重指数而异。
Nutrients. 2020 Apr 11;12(4):1065. doi: 10.3390/nu12041065.
4
Association of Full Breastfeeding Duration with Postpartum Weight Retention in a Cohort of Predominantly Breastfeeding Women.母乳喂养持续时间与以母乳喂养为主的队列产后体重滞留的相关性研究。
Nutrients. 2019 Apr 25;11(4):938. doi: 10.3390/nu11040938.
5
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.纤维化严重程度是晚期非酒精性脂肪性肝病患者死因特异性死亡率的决定因素:一项多国队列研究。
Gastroenterology. 2018 Aug;155(2):443-457.e17. doi: 10.1053/j.gastro.2018.04.034. Epub 2018 May 5.
6
The association between psychological factors and breastfeeding behaviour in women with a body mass index (BMI) ≥30 kg m : a systematic review.心理因素与 BMI≥30kg/m² 的女性母乳喂养行为之间的关系:系统评价。
Obes Rev. 2018 Jul;19(7):947-959. doi: 10.1111/obr.12681. Epub 2018 Mar 24.
7
Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的全球流行病学:我们未来的需求。
Liver Int. 2018 Feb;38 Suppl 1:47-51. doi: 10.1111/liv.13643.
8
The role of insulin - like growth factor - 1 on steatohepatitis.胰岛素样生长因子-1在脂肪性肝炎中的作用。
Acta Gastroenterol Belg. 2017 Jan-Mar;80(1):21-24.
9
Association between non-alcoholic fatty liver disease and cancer incidence rate.非酒精性脂肪性肝病与癌症发病率之间的关联。
J Hepatol. 2017 Nov 2. doi: 10.1016/j.jhep.2017.09.012.
10
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的全球负担:趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. doi: 10.1038/nrgastro.2017.109. Epub 2017 Sep 20.